Lumos Diagnostics Holdings (LDX) Stock Overview

Lumos Diagnostics Holdings Limited, a contract research and development company, develops, manufactures, and commercializes rapid point-of-care (POC) diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. The company's products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

LDX Stock Information

Symbol

LDX

Address

100 Albert RoadMelbourne, VIC 3205Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://lumosdiagnostics.com

Country

🇦🇺 Australia

Phone Number

61 3 9087 1598

Lumos Diagnostics Holdings (LDX) Price Chart

Lumos Diagnostics Holdings Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.026808559735579367	N/A
Market Cap	$6.30M	N/A
Shares Outstanding	234.84M	54.17%
Employees	0	N/A
Shareholder Equity	9.50M	-46.89%

Valuation	2023	Change
P/E Ratio	-0.70	N/A
P/S Ratio	0.60	N/A
P/B Ratio	0.66	N/A

Growth	2023	Change
Return on Equity	-0.9445	N/A

Earnings	2023	Change
Revenue	$10.54M	N/A
Earnings	-$8.97M	N/A
EPS	-0.0382	N/A
Earnings Yield	-1.42	N/A
Gross Margin	0.5669	N/A
Operating Margin	-0.9043	N/A
Net income margin	-0.8515	N/A

Financial Strength	2023	Change
Total Assets	$25.42M	N/A
Total Debt	$9.79M	N/A
Cash on Hand	$3.02M	N/A
Debt to Equity	$1.68	57.33%
Cash to Debt	0.3081	-72.22%
Current Ratio	0.7296	-30.36%